The company remains pre-revenue with zero reported sales, while operating losses expanded to $29.6 million in 2025Q4, indicating an accelerating burn rate during its developmental phase.
| Revenue | 0 | 0 | 0 |
| Revenue Growth % | - | - | - |
| Cost of Revenue | 10K | 0 | 0 |
| Gross Profit | -10K | 0 | 0 |
| Gross Margin % | - | - | - |
| Gross Profit Growth % | - | - | - |
| Operating Expenses | 33.69M | 152.3K | 43.7K |
| Other Operating Expenses | - | - | - |
| EBITDA | -33.7M | -152.3K | -43.7K |
| EBITDA Margin % | - | - | - |
| EBITDA Growth % | -22026.94% | -248.5% | - |
| Depreciation & Amortization | 0 | 0 | 0 |
| D&A / Revenue % | - | - | - |
| Operating Income (EBIT) | -33.7M | -152.3K | -43.7K |
| Operating Margin % | - | - | - |
| Operating Income Growth % | -22026.94% | -248.5% | - |
| Interest Expense | 1.43M | 0 | 0 |
| Interest Coverage | -23.63x | - | - |
| Interest / Revenue % | - | - | - |
| Non-Operating Income | 1000K | 129.1K | 38.9K |
| Pretax Income | 539.5M | -23.21K | -4.8K |
| Pretax Margin % | - | - | - |
| Income Tax | 0 | 10.37K | -327 |
| Effective Tax Rate % | 0% | -44.7% | 6.81% |
| Net Income | 539.5M | -33.58K | -4.47K |
| Net Margin % | - | - | - |
| Net Income Growth % | 1606663.24% | -650.92% | - |
| EPS (Diluted) | 9.74 | -0.00 | -0.00 |
| EPS Growth % | - | - | - |
| EPS (Basic) | 9.74 | -0.00 | -0.00 |
| Diluted Shares Outstanding | 55.39M | 29.17M | 29.17M |
High regulatory and execution risk
As indicated by the latest financial disclosures, NKLR remains a pre-revenue entity, with zero reported revenue across the last ten quarters, reflecting its current status as a developmental-stage nuclear technology firm rather than an operational utility provider with established rate-based income streams.
The absence of revenue confirms that the company has yet to achieve commercial milestones or secure power purchase agreements. Investors should monitor the transition from R&D to project-based revenue recognition, as the current lack of top-line growth necessitates reliance on external capital to fund ongoing operations.
Based on reported figures for 2025Q4, the company recorded an operating loss of $29.6 million, a significant expansion from the $2.3 million loss in 2025Q3, suggesting that the firm is accelerating its capital-intensive development phase despite the lack of any offsetting revenue streams.
This widening operating loss appears to reflect the high costs associated with specialized nuclear engineering and regulatory licensing efforts. The lack of cost recovery mechanisms, typical of regulated utilities, leaves the company fully exposed to these rising expenditures without the benefit of pass-through pricing.
According to the 2025Q4 income statement, NKLR reported a net income of $539.4 million and an EPS of 9.82, which stands in stark contrast to the underlying operating loss of $29.6 million, indicating that these earnings are driven by non-recurring or non-operating items.
The disconnect between the reported net income and the negative operating performance warrants extreme caution, as it suggests the presence of one-time accounting adjustments or asset revaluations. Investors should look past these headline figures to assess the sustainability of the company's core business model, which currently remains in a cash-burning state.
Quick answers to the most common questions about buying NKLR stock.
For fiscal year 2025, Terra Innovatum Global N.V. Ordinary shares (NKLR) reported total revenue of $0.0M.
Terra Innovatum Global N.V. Ordinary shares (NKLR) is profitable, generating $539.5M in net income for the fiscal year ending 2025.